Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion

Stem Cells and Development

Volumn 20, Issue 7, 2011, Pages 1143-1152

  Wang, Yong ^a   Kellner, Joshua ^a   Liu, Lingbo ^a,b   Zhou, Daohong ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHEMOKINE RECEPTOR CXCR4; FLT3 LIGAND; MITOGEN ACTIVATED PROTEIN KINASE P38; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL RENEWAL; CONTROLLED STUDY; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEM CELL EXPANSION;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CELL AGING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RECEPTORS, CXCR4; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 79959818068     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0413     Document Type: Article

References (37)

1. Kyriakis JM and J Avruch. (2001). Mammalian mitogenactivated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869. (Pubitemid 32267078)
2. Geest CR and PJ Coffer. (2009). MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 86:237-250.
3. Kirito K, N Fox and K Kaushansky. (2003). Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 102:3172-3178. (Pubitemid 37314753)
4. Nagata Y, T Moriguchi, E Nishida and K Todokoro. (1997). Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 90:929-934. (Pubitemid 27314124)
5. Rausch O and CJ Marshall. (1999). Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. J Biol Chem 274:4096-4105.
6. Katsoulidis E, Y Li, P Yoon, A Sassano, J Altman, P Kannan- Thulasiraman, L Balasubramanian, S Parmar, J Varga, MS Tallman, A Verma and LC Platanias. (2005). Role of the p38 mitogen-activated protein kinase pathway in cytokinemediated hematopoietic suppression in myelodysplastic syndromes. Cancer Res 65:9029-9037. (Pubitemid 41377395)
7. Verma A, DK Deb, A Sassano, S Kambhampati, A Wickrema, S Uddin, M Mohindru, BK Van and LC Platanias. (2002). Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokineinduced hemopoietic suppression in aplastic anemia. J Immunol 168:5984-5988. (Pubitemid 34620009)
8. Verma A, DK Deb, A Sassano, S Uddin, J Varga, A Wickrema and LC Platanias. (2002). Activation of the p38 mitogen- activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factorbeta on normal hematopoiesis. J Biol Chem 277:7726-7735. (Pubitemid 34968219)
9. Zhou L, J Opalinska and A Verma. (2007). p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle 6:534-537. (Pubitemid 46440424)
10. Tamura K, T Sudo, U Senftleben, AM Dadak, R Johnson and M Karin. (2000). Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102:221-231.
11. Hui L, L Bakiri, A Mairhorfer, N Schweifer, C Haslinger, L Kenner, V Komnenovic, H Scheuch, H Beug and EF Wagner. (2007). p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39:741-749. (Pubitemid 46848584)
12. Ventura JJ, S Tenbaum, E Perdiguero, M Huth, C Guerra, M Barbacid, M Pasparakis and AR Nebreda (2007). p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 39:750-758. (Pubitemid 46848588)
13. NavasTA, M Mohindru, M Estes, JY Ma, L Sokol, P Pahanish, S Parmar, E Haghnazari, L Zhou, R Collins, I Kerr, AN Nguyen, Y Xu, LC Platanias, AA List, LS Higgins and A Verma. (2006). Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood 108:4170-4177. (Pubitemid 44913289)
14. Ito K, A Hirao, F Arai, K Takubo, S Matsuoka, K Miyamoto, M Ohmura, K Naka, K Hosokawa, Y Ikeda and T Suda. (2006). Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12:446-451.
15. Miyamoto K, KY Araki, K Naka, F Arai, K Takubo, S Yamazaki, S Matsuoka, T Miyamoto, K Ito, M Ohmura, C Chen, K Hosokawa, H Nakauchi, K Nakayama, KI Nakayama, M Harada, N Motoyama, T Suda and A Hirao. (2007). Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1:101-112. (Pubitemid 46865800)
16. Hofmeister CC, J Zhang, KL Knight, P Le and PJ Stiff. (2007). Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 39:11-23. (Pubitemid 44921650)
17. Kelly SS, CB Sola, LM de Lima and E Shpall. (2009). Ex vivo expansion of cord blood. Bone Marrow Transplant 44:673-681.
18. Reya T. (2003). Regulation of hematopoietic stem cell selfrenewal. Recent Prog Horm Res 58:283-295. (Pubitemid 37339314)
19. Hermitte F, P Brunet de la Grange, F Belloc, V Praloran and Z Ivanovic. (2006). Very low O2 concentration (0.1%) favors G0 return of dividing CD34 + cells. Stem Cells 24:65-73.
20. Ivanovic Z, SP Dello, F Trimoreau, JL Faucher and V Praloran. (2000). Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion 40:1482-1488. (Pubitemid 32049053)
21. Ivanovic Z, F Hermitte, P Brunet de la Grange, B Dazey, F Belloc, F Lacombe, G Vezon and V Praloran. (2004). Simultaneous maintenance of human cord blood SCIDrepopulating cells and expansion of committed progenitors at low O2 concentration (3%). Stem Cells 22:716-724. (Pubitemid 39166929)
22. Cirillo PF, C Pargellis and J Regan. (2002). The non-diaryl heterocycle classes of p38 MAP kinase inhibitors. Curr Top Med Chem 2:1021-1035.
23. Wang Y, BA Schulte, AC LaRue, M Ogawa and D Zhou. (2006). Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 107:358-366. (Pubitemid 43053564)
24. Ploemacher RE, JP van der Sluijs, JS Voerman and NH Brons. (1989). An in vitro limiting-dilution assay of longterm repopulating hematopoietic stem cells in the mouse. Blood 74:2755-2763. (Pubitemid 20007803)
25. Von DA, G Alespeiti, L Ren and JW Adamson. (2004). Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev 13:101-111. (Pubitemid 38560047)
26. Sharpless NE. (2005). INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 576:22-38. (Pubitemid 40982680)
27. Sharpless NE and RA DePinho. (2007). How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8:703-713. (Pubitemid 47312828)
28. Antonchuk J, G Sauvageau and RK Humphries. (2002). HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39-45. (Pubitemid 34327515)
29. Broxmeyer HE. (2008). Chemokines in hematopoiesis. Curr Opin Hematol 15:49-58. (Pubitemid 350191028)
30. Madlambayan GJ, I Rogers, DC Kirouac, N Yamanaka, F Mazurier, M Doedens, RF Casper, JE Dick and PW Zandstra. (2005). Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol 33:1229-1239. (Pubitemid 41416972)
31. Waegell WO, HR Higley, PW Kincade and JR Dasch. (1994). Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta. Exp Hematol 22:1051-1057. (Pubitemid 24314769)
32. Iwasa H, J Han and F Ishikawa. (2003). Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8:131-144. (Pubitemid 36511698)
33. Kwong J, L Hong, R Liao, Q Deng, J Han and P Sun. (2009). p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J Biol Chem 284:11237-11246.
34. Dimri GP, X Lee, G Basile, M Acosta, G Scott, C Roskelley, EE Medrano, M Linskens, I Rubelj, O Pereira-Smith, M Peacocke and J Campici. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367.
35. Amsellem S, F Pflumio, D Bardinet, B Izac, P Charneau, PH Romeo, A Dubart-Kupperschmitt and S Fichelson. (2003). Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med 9:1423-1427. (Pubitemid 37466194)
36. Csaszar E, G Gavigan, M Ungrin, C Therien, P Dube, J Fethiere, G Sauvageau, DC Roy and PW Zandstra. (2009). An automated system for delivery of an unstable transcription factor to hematopoietic stem cell cultures. Biotechnol Bioeng 103:402-412.
37. Tang Y, J Chen and NS Young. (2009). Expansion of haematopoietic stem cells from normal donors and bone marrow failure patients by recombinant hoxb4. Br J Haematol 144:603-612.